FPL 65447

Drug Profile

FPL 65447

Alternative Names: FPL 65447AA

Latest Information Update: 12 May 1995

Price : $50

At a glance

  • Originator Fisons
  • Class Antihypertensives; Cardiotonics; Small molecules; Vasodilators
  • Mechanism of Action Dopamine D1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Hypertension; Oliguria

Most Recent Events

  • 12 May 1995 Discontinued-Preclinical for Oliguria in United Kingdom (Unknown route)
  • 12 May 1995 Discontinued-Preclinical for Congestive heart failure in United Kingdom (Unknown route)
  • 07 Apr 1995 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top